ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

AHG vs RSKD // EV/EBITDA & P/E VALUATION

Akso Health Group ADS (NASDAQ) VS. Riskified Ltd. (Class A) (NYSE) • 15-METRIC TALLY: AHG 0 — RSKD 8
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AHG VS. RSKD) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC AHG RSKD SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin -0.10% 51.70% -51.80 RSKD /gross-margins <GO>
Return on Invested Capital (ROIC) — -20.30% — TIE /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield -1.12% 2.71% -3.83 RSKD /fcf-yield <GO>
Operating Margin -60.00% -9.90% -50.10 RSKD /operating-margins <GO>
Net Profit Margin -60.00% -8.00% -52.00 RSKD /net-margins <GO>
Revenue Growth (YoY) -6.40% 5.20% -11.60 RSKD /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 6.12 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 7/9 -5.00 RSKD /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 53.8 55.6 -1.81 RSKD /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $1.14B $1.22B -$82.9M RSKD /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR AHG REV RSKD REV AHG GROSS % RSKD GROSS % AHG FCF RSKD FCF
FY 2025 $13.8M $344.6M -0.1% 51.7% -$12.8M $33.1M
FY 2024 $14.8M $327.5M -1.9% 52.2% $1.0M $39.1M
FY 2023 $2.4M $297.6M — — $1.4M $7.3M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AHG // BETA —
RSKD // BETA —